MarketCap
Facebook
X
Telegram
HealthEquity Retained Earnings | HQY
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings HealthEquity
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 196 M | 209 M | 206 M | 150 M | 176 M | 220 M | 212 M | 172 M | 85.3 M | 30 M | 3.61 M | -13 M | -23.2 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 220 M | -23.2 M | 125 M |
Quarterly Retained Earnings HealthEquity
| 2027-Q2 | 2027-Q1 | 2026-Q4 | 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 196 M | 177 M | 209 M | 208 M | 227 M | 218 M | 206 M | 208 M | 227 M | 218 M | 209 M | 232 M | 270 M | 234 M | 206 M | 179 M | 165 M | - | 150 M | 150 M | 152 M | 162 M | 220 M | 209 M | 214 M | 218 M | 212 M | 215 M | 213 M | 213 M | 172 M | 212 M | 233 M | 214 M | 85.3 M | 159 M | 143 M | 121 M | 30 M | 79.4 M | 68.9 M | 52.1 M | 3.61 M | 25.9 M | 19.9 M | 11.7 M | -13 M | 481 K | -3.61 M | -8.03 M | -23.2 M | -14.4 M | -17.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 270 M | -23.2 M | 144 M |
Retained Earnings of other stocks in the Health information services industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Omnicell
OMCL
|
385 M | $ 34.64 | 3.1 % | $ 1.59 B |  USA |
 |
OptimizeRx Corporation
OPRX
|
-79.2 M | $ 8.72 | 1.75 % | $ 162 M | USA |
 |
Progyny
PGNY
|
203 M | $ 25.86 | 2.5 % | $ 2.2 B | USA |
 |
Phreesia
PHR
|
-799 M | $ 10.37 | 2.88 % | $ 619 M | USA |
 |
Schrödinger
SDGR
|
-629 M | $ 32.6 | 7.56 % | $ 2.39 B | USA |
 |
So-Young International
SY
|
-1.17 B | $ 2.74 | 0.36 % | $ 213 M |  China |
 |
Teladoc Health
TDOC
|
-16.4 B | $ 5.79 | 4.89 % | $ 1.02 B | USA |
 |
10x Genomics
TXG
|
-1.51 B | $ 97.74 | 4.53 % | $ 12.2 B | USA |
 |
Veeva Systems
VEEV
|
4.36 B | $ 283.45 | 3.7 % | $ 46.4 B | USA |
 |
Zhongchao
ZCMD
|
-14.2 M | $ 1.91 | 3.24 % | $ 6.53 M | China |
 |
NantHealth
NH
|
-1.12 B | - | -46.64 % | $ 10.4 M | USA |
 |
Covetrus
CVET
|
-1.08 B | - | - | $ 2.94 B | USA |
 |
1Life Healthcare
ONEM
|
-1.02 B | - | - | $ 3.37 B | USA |
 |
R1 RCM
RCM
|
-64.3 M | - | - | $ 3.81 B | USA |
 |
Change Healthcare
CHNG
|
-1.1 B | - | - | $ 9.03 B | USA |
 |
Signify Health
SGFY
|
-558 M | - | -0.02 % | $ 7.21 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
-408 M | - | - | $ 255 M | USA |
 |
Cerner Corporation
CERN
|
6.75 B | - | - | $ 27.9 B | USA |
 |
iCAD
ICAD
|
-277 M | - | - | $ 102 M | USA |
 |
NextGen Healthcare
NXGN
|
128 M | - | - | $ 1.6 B | USA |
 |
Accolade
ACCD
|
-1.05 B | - | 0.29 % | $ 206 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
403 M | - | -10.39 % | $ 886 M | USA |
 |
Castlight Health, Inc.
CSLT
|
-517 M | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
580 M | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
301 M | - | - | $ 6.37 B | USA |
 |
Computer Programs and Systems
CPSI
|
-12.2 M | - | 4.4 % | $ 133 M | USA |
 |
Akerna Corp.
KERN
|
-52.5 M | - | - | $ 161 M | USA |
 |
MTBC
MTBC
|
-55.8 M | - | -0.58 % | $ 51.7 M | USA |
 |
Premier
PINC
|
-485 M | - | - | $ 2.33 B | USA |
 |
Streamline Health Solutions
STRM
|
-126 M | - | - | $ 21.4 M | USA |
 |
SCWorx Corp.
WORX
|
-35.4 M | - | - | $ 7.71 M | USA |
 |
American Well Corporation
AMWL
|
-2.06 B | $ 12.72 | 2.66 % | $ 204 M | USA |
 |
Evolent Health
EVH
|
-1.32 B | $ 3.61 | 4.34 % | $ 412 M | USA |
 |
GoodRx Holdings
GDRX
|
-1.41 B | $ 3.36 | 2.44 % | $ 1.2 B | USA |
 |
Health Catalyst
HCAT
|
-1.36 B | $ 1.76 | 0.57 % | $ 123 M | USA |
 |
HealthStream
HSTM
|
124 M | $ 31.54 | 2.34 % | $ 947 M | USA |